BBLG
Bone Biologics·NASDAQ
--
--(--)
--
--(--)
BBLG fundamentals
Bone Biologics (BBLG) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.33 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-1.33
--
Report date
Aug 14, 2025
EPS
Actual | -100.8 | -81.12 | -29.28 | -35.34 | -7.86 | -0.32 | -1.33 | ||||
Forecast | -288 | -172.8 | -81.12 | -29.28 | -282.72 | -7.86 | -4.02 | -3.6 | -3.54 | -3.24 | -0.58 |
Surprise | +65.00% | 0.00% | 0.00% | 0.00% | +87.50% | 0.00% | 0.00% | 0.00% | 0.00% | +90.12% | -129.31% |
Revenue
Actual | 0 | -- | 0 | 0 | 0 | 0 | -- | -- | -- | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Bone Biologics's earnings call?What guidance did Bone Biologics's management provide for the next earnings period?What factors drove the changes in Bone Biologics's revenue and profit?What does Bone Biologics do and what are its main business segments?What is the revenue and EPS growth rate for Bone Biologics year over year?What is Bone Biologics's latest dividend and current dividend yield?What is the market's earnings forecast for Bone Biologics next quarter?Did Bone Biologics beat or miss consensus estimates last quarter?
